Research Calls
- Upgrades:
- CONMED (CNMD) upgraded to Overweight from Sector Weight at KeyBanc Capital Markets; tgt $124
- Corning (GLW) upgraded to Buy from Hold at Deutsche Bank; tgt raised to $38
- Equinix (EQIX) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt raised to $785
- KeyCorp (KEY) upgraded to Buy from Neutral at Citigroup; tgt $20
- Marqeta (MQ) upgraded to Outperform from Peer Perform at Wolfe Research; tgt $5.50
- M&T Bank (MTB) upgraded to Buy from Neutral at Citigroup; tgt lowered to $155
- Orange (ORAN) upgraded to Overweight from Equal-Weight at Morgan Stanley
- Pinterest (PINS) upgraded to Buy from Neutral at UBS; tgt raised to $35
- Regeneron Pharma (REGN) upgraded to Outperform from Market Perform at SVB Securities; tgt raised to $976
- Roku (ROKU) upgraded to Positive from Neutral at Susquehanna; tgt $75
- Sanofi (SNY) upgraded to Overweight from Equal Weight at Barclays
- Victory Capital (VCTR) upgraded to Overweight from Underweight at Piper Sandler; tgt raised to $35
- Virtus Investment Partners (VRTS) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $260
- Downgrades:
- Caterpillar (CAT) downgraded to Underperform from Neutral at Robert W. Baird; tgt lowered to $185
- Digital Realty Trust (DLR) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt lowered to $100
- DISH Network (DISH) downgraded to Neutral from Buy at UBS; tgt lowered to $10
- Frontier Communications Parent (FYBR) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt lowered to $19
- Leidos (LDOS) downgraded to Hold from Buy at Jefferies; tgt lowered to $95
- Ollie's Bargain Outlet (OLLI) downgraded to Sell from Neutral at Citigroup; tgt lowered to $49
- Remitly Global (RELY) downgraded to Peer Perform from Outperform at Wolfe Research
- United Rentals (URI) downgraded to Underperform from Neutral at Robert W. Baird; tgt lowered to $300
- Wingstop (WING) downgraded to Underperform from Hold at Jefferies; tgt $160
- Others:
- Cogent Biosciences (COGT) assumed with a Buy at H.C. Wainwright; tgt $28
- Halozyme Therapeutics (HALO) resumed with a Buy at Berenberg; tgt $58
- Model N (MODN) initiated with an Overweight at Morgan Stanley; tgt $43